Einrichtung einer Expertengruppe zur Bewertung des Off-Label-Gebrauchs bei ME/CFS

This question asks the German government about establishing an expert group to assess the off-label use of medications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). It highlights concerns about current treatment approaches. The inquiry seeks to understand the government's plans to improve treatment options and patient care for those suffering from ME/CFS, potentially impacting patients and healthcare providers.